Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

224
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
224
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Understanding women's knowledge and perceived benefits of vaginal birth and caesarean section: A multi-country survey from the QUALI-DEC project.

Women and birth : journal of the Australian College of Midwives·2026
Same author

Trial trustworthiness assessment: commentary on the Cochrane 2025 systematic review on calcium supplementation during pregnancy.

Reproductive health·2026
Same author

Revisiting the Epistemological Foundations of Evidence-Based Medicine.

Journal of evaluation in clinical practice·2026
Same author

Efficacy and Safety of Cannabis Derivates and Their Synthetic Analogs. Overview of Systematic Reviews.

Phytotherapy research : PTR·2026
Same author

Medullary thyroid carcinoma and RET molecular testing: A virtual tumor board on clinical decision-making.

CA: a cancer journal for clinicians·2026
Same author

The real-world evidence debate: why proper terminology matters.

Journal of clinical epidemiology·2026

相关实验视频

Updated: Jul 28, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.4K

阿拉姆图祖马布用于多发性硬化症.

Rachel Riera1,2,3, Maria Regina Torloni4, Ana Luiza C Martimbianco1,2,3,5

  • 1Cochrane Brazil Rio de Janeiro, Petrópolis Medical School, Petrópolis, Brazil.

The Cochrane database of systematic reviews
|June 5, 2023
PubMed
概括

与干扰素β-1a相比,阿勒姆图祖马布可以改善无复发的生存率,并减少多发性硬化症 (MS) 患者的残疾. 然而,证据的确定性很低,两种治疗方法的不良事件都很常见.

更多相关视频

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

6.5K
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.4K

相关实验视频

Last Updated: Jul 28, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.4K
Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

6.5K
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.4K

科学领域:

  • 神经学 神经学
  • 免疫学 免疫学 免疫学
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 多发性硬化症 (MS) 是一种慢性自身免疫性疾病,影响中枢神经系统.
  • 目前的治疗方法旨在控制恶化和减缓残疾进展.
  • 现有的任何疗法都不能安全有效地完全实现这些目标.

研究的目的:

  • 评估阿勒姆图祖马布在治疗多发性硬化症中的疗效和安全性.
  • 为了与安慰剂,其他活性药物或不同的阿勒姆图祖马布治疗方案进行对比,阿勒姆图祖马布.

主要方法:

  • 进行了随机对照试验 (RCT) 的系统审查.
  • 包括三项与1713名参与者进行的RCT,将阿姆图祖马布与干扰素β-1a进行比较.
  • 评估结果包括无复发的生存率,疾病进展,不良事件和残疾.

主要成果:

  • 阿拉姆图祖马布在36个月后显示出无复发生存率和持续无疾病进展生存率的潜在改善.
  • 随着阿勒姆图祖马布的使用,人们观察到残疾的轻微减少.
  • 参与者经历不良事件的比例在阿姆图祖马布和干扰素β-1a组之间是相似的.

结论:

  • 与干扰素β-1a相比,阿勒姆图祖马布在治疗复发性复发性多发性硬化症方面可能有好处.
  • 这些发现的证据确定性低至非常低.
  • 需要进一步的研究才能充分了解长期的好处和风险.